Press release
Viscosupplementation Market Share, Trends, Size, Growth & Forecast 2023-2028
IMARC Group, a leading market research company, has recently released a report titled "Viscosupplementation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028". The study provides a detailed analysis of the industry, including the viscosupplementation market size, share, trends and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.How big is the Viscosupplementation Market?
The global viscosupplementation market size reached US$ 4.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.8 Billion by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028.
What is Viscosupplementation?
Viscosupplementation is a minimally invasive medical procedure that involves the injection of a gel-like fluid derived from exogenous hyaluronic acid (HA) directly into the knee joints, which acts as a lubricant, facilitating smooth movement between bones, reducing inflammation, and serving as a shock absorber for joint loads of the patients. It minimizes friction during the movements, helps the synovial fluids create more cushion, alleviates severe pain, and enhances the motions or movements in the joint. Moreover, it restores the rheological properties of the synovial fluids, resulting in mechanical, analgesic, anti-inflammatory, and chondroprotective effects. Moreover, it is available in high molecular weights, including intermediate, low, and high, to treat osteoarthritis in the knee, hip, and hand, catering to different patient needs and preferences. Nowadays, viscosupplementation is widely adopted in hospitals and orthopedic clinics across the globe.
Request for a sample copy of this report: https://www.imarcgroup.com/viscosupplementation-market/requestsample
What are the growth prospects and trends in the viscosupplementation industry?
The market is primarily driven by the growing occurrences of osteoporosis and osteoarthritis (OA) due to reduced bone strength and less bone mineral density, and bone mass owing to some variation in bone structure quality. Additionally, the growing geriatric population, increasing prevalence of obesity, the rising demand for non-surgical treatment options for osteoarthritis, and the widespread adoption of viscosupplementation for joint pain management and as an alternative to corticosteroids are contributing to the market growth. In line with this, the numerous benefits of non-surgical treatments, such as minimized expenses, lower complications, minimal invasiveness, and improved clinical outcomes and recovery rates, are influencing the market growth. Moreover, numerous favorable government initiatives and investments by pharmaceutical companies in introducing novel drugs and different administration routes represent another major growth-inducing factor. Besides this, the development of hyaluronic acid-based therapies and the presence of ambulatory surgical centers (ACS) that provide comprehensive treatment for surgical and non-surgical issues in numerous body parts, including ligaments, muscles, joints, nerves, and spines, are accelerating the product adoption rate. Apart from this, the viscosupplementation market is growing at different rates in numerous regions, with North America being the largest market due to the growing geriatric population prone to disorders, such as osteoarthritis, and the availability of affordable health insurance reimbursement policies across the region. Moreover, the industry is expected to face competition in the upcoming years as numerous key players are implementing competitive strategies to sustain their presence in the market. For instance, in May 2021, Ono Pharmaceutical Co., Ltd. and Seikagaku Corporation introduced JOYCLU 30mg intra-articular injection, a joint function improvement agent for which Seikagaku received the production and marketing approval in March 2021 in Japan. Furthermore, favorable health insurance reimbursement policies, collaborations and partnerships among key players, and continuous research and development (R&D) activities in the medical field are creating a positive market outlook.
Browse Full Report with Table of Content : https://www.imarcgroup.com/viscosupplementation-market
What is included in market segmentation?
The report has segmented the market into the following categories:
Type Insights:
Single Injection
Three Injection
Five Injection
Age Group Insights:
Adults
Geriatrics
Distribution Channel Insights:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Application Insights:
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Others
End Use Insights:
Hospitals
Orthopedic Clinics
Others
Market Breakup by Region:
North America (United States, Canada)
Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Anika Therapeutics Inc.
Aptissen S.A.
Bioventus LLC
Ferring Pharmaceuticals
Fidia Farmaceutici S.p.A.
Johnson & Johnson
LG Chem Ltd.
OrthogenRx Inc. (Avanos Medical Inc.)
Sanofi S.A.
Seikagaku Corporation
Virchow Biotech Private Limited
Zimmer Biomet
Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited)
Ask an Analyst : https://www.imarcgroup.com/request?type=report&id=6931&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Viscosupplementation Market Share, Trends, Size, Growth & Forecast 2023-2028 here
News-ID: 3126383 • Views: …
More Releases from IMARC Group

Global Cellulose Prices Q2 2025 - Trend, News & Insights
North America Cellulose Prices Movement Q2
Cellulose Prices in United States:
In Q2 2025, US Cellulose Prices were pressured by reduced output at pulp mills due to maintenance and labor shortages. Timber harvesting delays from adverse weather constrained raw material supply. Steady demand from packaging and construction supported consumption, while rising fuel surcharges and logistics costs added to overall pricing challenges.
Get the Real-Time Prices Analysis: https://www.imarcgroup.com/cellulose-pricing-report/requestsample
APAC Cellulose Prices Movement Q2:
Cellulose Prices in…

E-Waste Manufacturing Plant Report 2025: Raw Materials Requirement, Setup Cost a …
E-Waste refers to discarded electronic devices such as computers, smartphones, televisions, and household appliances that have reached the end of their life cycle. It contains both valuable materials like gold, copper, and rare earth elements, as well as hazardous substances such as lead, mercury, and cadmium, making proper recycling crucial for environmental safety and resource recovery.
Setting up an e-waste recycling plant requires investment in land, machinery for dismantling and extraction,…

Cement Bricks Manufacturing Plant Report 2025: Business Plan, and Setup Details
Cement bricks are solid or hollow rectangular blocks made from a mixture of cement, sand, and aggregates, molded and cured for strength and durability. They are widely used in construction due to their uniform shape, load-bearing capacity, resistance to fire and weather, and cost-effectiveness compared to traditional clay bricks.
Setting up a cement bricks manufacturing plant involves securing land, installing machinery like mixers and molding units, sourcing raw materials, and employing…

Propyl Cyanoacetate Production Cost Report 2025: Detailed Guide on Plant Setup, …
Setting up a propyl cyanoacetate production facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Propyl Cyanoacetate Production Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a propyl cyanoacetate…
More Releases for Viscosupplementation
Viscosupplementation Market Report, History and Forecast 2023-2031
Newark, New Castle, USA - Growth Plus Reports has published a new report on Viscosupplementation Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Viscosupplementation provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive and statistical…
Hampering the growth of the viscosupplementation market 2021
Viscosupplementation is a minimally invasive procedure that involves injection of the hyaluronic acid injected into a knee joint to promote better joint development and lubrication. It also helps in reducing pain, irritation and helps in improving osteoarthritis condition. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Increasing prevalence of osteoarthritis in people is expected to boost…
Understanding Impact of COVID-19 on Viscosupplementation Market
According to the report, the global viscosupplementation market was valued at ~US$ 2.6 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Viscosupplementation can be performed using three primary injection types: single injection, three injections, and five injections. Applications of viscosupplementation injection include knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis. Growth of the global viscosupplementation market can be attributed to rise in…
The three injection viscosupplementation product type segment is projected to be …
Russia’s healthcare infrastructure will continue witnessing significant rise in number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by people’s eating & drink habits, their proactive lifestyles and the country’s harsh weather conditions. Rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementation…
Viscosupplementation Market
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia…
Viscosupplementation Market: Three Injection Viscosupplementation Likely to be t …
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia…